文献速递生殖医学

单细胞RNA测序揭示卵巢刺激后卵母细胞体外成熟不良的分子靶点

Single-cell RNA sequencing identifies molecular targets associated with poor in vitro maturation performance of oocytes collected from ovarian stimulation.
PubMed 文献 · Hum Reprod · 2021-01-01

该研究对来自7名供者的10个体内成熟卵母细胞(IVO)和来自10名供者的10个补救性体外成熟(rIVM)卵母细胞进行单细胞RNA测序,发现rIVM卵母细胞中GATA-1/CREB1/WNT信号轴受抑制,尤其在低质量卵母细胞中更明显;在鼠卵母细胞IVM培养基中加入没食子酸可使成熟率提高31.1%。

要点

  • rIVM卵母细胞与IVO卵母细胞转录组存在显著差异,1559个差异表达基因富集于代谢、生物合成和氧化磷酸化。
  • GATA-1/CREB1/WNT信号轴在rIVM卵母细胞中受抑制,低质量rIVM卵母细胞中进一步下调。
  • 没食子酸作为潜在抗氧化剂可使小鼠卵母细胞成熟率提高31.1%。

核心结论

  • GATA-1/CREB1/WNT信号轴在rIVM卵母细胞中受抑制,尤其低质量卵母细胞,恢复该轴可能产生更多可用rIVM卵母细胞。

研究设计与样本

  • 应用单细胞RNA测序比较人IVO卵母细胞(n=10,来自7名供者)和rIVM卵母细胞(n=10,来自10名供者)的转录组。
  • 并行研究没食子酸对小鼠卵母细胞IVM成熟率的影响,含没食子酸组n=84,不含组n=85。

主要发现

  • rIVM与IVO卵母细胞间鉴定出1559个差异表达基因(至少2倍变化且校正P<0.05),富集于代谢过程、生物合成和氧化磷酸化。
  • 与IVO卵母细胞相比,rIVM卵母细胞中WNT/β-catenin信号受抑制。
  • 雌二醇水平与每位供者的IVO成熟卵母细胞比例(MII比例)呈年龄非依赖性显著相关。
  • 高MII比例年轻供者的rIVM卵母细胞中抗凋亡等细胞过程过代表,CREB1是重要调节因子。
  • 没食子酸使小鼠卵母细胞成熟率提高31.1%。

关键数值与推荐

  • 差异表达基因定义为至少2倍变化且校正P<0.05。
  • 没食子酸使用浓度为10 μM。

临床怎么用

  • 研究提示GATA-1/CREB1/WNT信号轴可作为改善人rIVM卵母细胞质量的潜在靶点。
  • 没食子酸作为抗氧化剂在鼠卵母细胞IVM中显示提高成熟率的效果,但尚未在人卵母细胞中验证。

局限性

  • 高、低质量rIVM卵母细胞比较中,经严格筛选标准过滤后样本量有限。
  • 卵母细胞阶段鉴定无法预测纺锤体存在,仅以极体排出为指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the transcriptome signature associated with poor performance of rescue IVM (rIVM) oocytes and how can we rejuvenate them? SUMMARY ANSWER: The GATA-1/CREB1/WNT signalling axis was repressed in rIVM oocytes, particularly those of poor quality; restoration of this axis may produce more usable rIVM oocytes. WHAT IS KNOWN ALREADY: rIVM aims to produce mature oocytes (MII) for IVF through IVM of immature oocytes collected from stimulated ovaries. It is not popular due to limited success rate in infertility treatment. Genetic aberrations, cellular stress and the absence of cumulus cell support in oocytes could account for the failure of rIVM. STUDY DESIGN, SIZE, DURATION: We applied single-cell RNA sequencing (scRNA-seq) to capture the transcriptomes of human in vivo oocytes (IVO) (n = 10) from 7 donors and rIVM oocytes (n = 10) from 10 donors. The effects of maternal age and ovarian responses on rIVM oocyte transcriptomes were also studied. In parallel, we studied the effect of gallic acid on the maturation rate of mouse oocytes cultured in IVM medium with (n = 84) and without (n = 85) gallic acid. PARTICIPANTS/MATERIALS, SETTING, METHODS: Human oocytes were collected from donors aged 28-41 years with a body mass index of <30. RNA extraction, cDNA generation, library construction and sequencing were performed in one preparation. scRNA-seq data were then processed and analysed. Selected genes in the rIVM versus IVO comparison were validated by quantitative real-time PCR. For the gallic acid study, we collected immature oocytes from 5-month-old mice and studied the effect of 10-μM gallic acid on their maturation rate. MAIN RESULTS AND THE ROLE OF CHANCE: The transcriptome profiles of rIVM/IVO oocytes showed distinctive differences. A total of 1559 differentially expressed genes (DEGs, genes with at least 2-fold change and adjusted P < 0.05) were found to be enriched in metabolic processes, biosynthesis and oxidative phosphorylation. Among these DEGs, we identified a repression of WNT/β-catenin signalling in rIVM when compared with IVO oocytes. We found that oestradiol levels exhibited a significant age-independent correlation with the IVO mature oocyte ratio (MII ratio) for each donor. rIVM oocytes from women with a high MII ratio were found to have over-represented cellular processes such as anti-apoptosis. To further identify targets that contribute to the poor clinical outcomes of rIVM, we compared oocytes collected from young donors with a high MII ratio with oocytes from donors of advanced maternal age and lower MII ratio, and revealed that CREB1 is an important regulator. Thus, our study identified that GATA-1/CREB1/WNT signalling was repressed in both rIVM oocytes versus IVO oocytes and in rIVM oocytes of lower versus higher quality. Consequently we investigated gallic acid, as a potential antioxidant substrate in human rIVM medium, and found that it increased the mouse oocyte maturation rate by 31.1%. LARGE SCALE DATA: Raw data from this study can be accessed through GSE158539. LIMITATIONS, REASONS FOR CAUTION: In the rIVM oocytes of the high- and low-quality comparison, the number of samples was limited after data filtering with stringent selection criteria. For the oocyte stage identification, we were unable to predict the presence of oocyte spindle, so polar body extrusion was the only indicator. WIDER IMPLICATIONS OF THE FINDINGS: This study showed that GATA-1/CREB1/WNT signalling was repressed in rIVM oocytes compared with IVO oocytes and was further downregulated in low-quality rIVM oocytes, providing us the foundation of subsequent follow-up research on human oocytes and raising safety concerns about the clinical use of rescued oocytes. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the Collaborative Research Fund, Research Grants Council, C4054-16G, and Research Committee Funding (Research Sustainability of Major RGC Funding Schemes), The Chinese University of Hong Kong. The authors have no conflicts of interest to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lee AWT, Ng JKW, Liao J, et al. Single-cell RNA sequencing identifies molecular targets associated with poor in vitro maturation performance of oocytes collected from ovarian stimulation. Hum Reprod. 2021. PMID: 34052851. doi:10.1093/humrep/deab100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。